The nation of Zimbabwe has turned down a significant US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years because of Washington's demand for confidential data.
This move became public following a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".
An official spokesman later explained that the US was demanding access to biological samples for scientific study and commercial gain but refused to share the benefits from future vaccines.
"We are forced to start the challenging and unfortunate process of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for continued dialogue to secure a deal acceptable to all parties so the nation's vital HIV programme can be sustained.
Broader Background
Zimbabwe's decision follows a similar case in neighbouring Kenya, where a court suspended a similar health funding agreement following concerns were raised about the safety of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
The agency had overseen aid for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance openness and responsibility.
As per statements, Sixteen African countries have so far signed similar health pacts, representing more than $18.3bn of fresh investment.
Details of the Rejected Agreement
The funds for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment via American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"Our nation was requested to surrender its genetic material and health information over an extended period, with no equivalent promise of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that provided information," Mangwana explained.
"Effectively, our country would supply the basic resources for medical research without any assurance that the final treatments would be accessible to our people if a new pandemic arise."
National Interest and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting structures already set up via the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing framework created to manage potential pandemics.
"This framework is designed to guarantee that when a nation contributes its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to create them."
These objections over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We encourage further dialogue with our US partners on how future collaboration could be designed in a manner that respects the independence and dignity of both nations."
Health Experts Response
A leading public health body said it acknowledged the official position, but urged that talks need to persist given that a large portion of the nation's HIV programmes were funded by international support.
"If technical issues arise, such as those relating to information security or agreement terms, these can often be resolved via detailed discussion and negotiated safeguards," the group added.
The halted deal emphasises the complex debate between accepting crucial international aid and protecting national sovereignty in an ever more interconnected world.